Search results
CanaQuest Announces Key Appointments to Team to Drive CQ-001 through Clinical Trials
Digital Journal· 6 days agoThe team plans to effectively navigate the regulatory approval process for Drug Candidate, CQ-001 (cannabidiol + proprietary API composition), to treat rare neurological conditions ...
Innovent to Present Multiple Clinical Study Results of Mazdutide at the ADA's 84th Scientific...
Benzinga· 6 days agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology ...
Larry Magid: Hearing aids are cool now
San Jose Mercury News· 4 days agoWhen I was a child, I couldn’t help noticing my grandfather’s large, flesh-colored hearing aids, but this weekend I sat across from a friend and didn’t...
Does Viagra Help Me Last Longer in Bed?
MediaFeed via AOL· 6 days agoBecause brand name Viagra, also known as sildenafil citrate, is thought of as a “cure-all” for intimate ailments (but mostly for ED), many men turn to it...
...R&D Agreement with Calypso Pharmaceuticals to Develop Nano-Emulsified Topical Targeting Melanoma...
Benzinga· 6 days agoSIPP Industries, Inc. SIPC, a multifaceted corporation specializing in the manufacturing and distribution of commercial and consumer products in the cannabis industry, is pleased to announce ...
Can Adderall Help With My Anxiety?
MediaFeed via AOL· 2 days agoAdderall and anxiety: Two things that don’t mix too terribly well. Adderall is a medication used to treat attention-deficit/hyperactivity disorder...
3 Healthcare Dividend Stocks to Buy Now
TheStreet.com· 2 days agoThe healthcare sector offers an opportunity for long-term growth and dividends, with these three companies at the top of our list. The U.S. healthcare...
Biophytis Announces the Successful Industrial Transfer of BIO101
Digital Journal· 6 days agoBIO101 (20-hydroxyecdysone), our lead drug candidate, is a small molecule in development for muscular (sarcopenia, phase 3 ready and Duchenne muscular dystrophy), respiratory ...
FSD Pharma Enters Into an Exclusive Option Agreement With the University of Southern California To...
The Joplin Globe· 4 days agoTORONTO, ON / ACCESSWIRE / June 13, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), a biopharmaceutical company dedicated to building a portfolio of innovative assets ...
HAIR SUPPLEMENTS: ARE THEY WORTH THE HYPE? ISHRS HAIR RESTORATION EXPERTS EXAMINE THE SCIENCE BEHIND...
The Parsons Sun· 3 days agoDespite the glowing testimonials from consumers in advertisements promoting hair supplements to combat hair loss and thinning, hair restoration experts warn that consuming supplements without ...
